European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

6 EU fundings (total €1,733,820): Innovative Strategies to Generate Human Hepatocytes for Treatment of Metabolic Liver Diseases: Tools for Personalized Cell Therapy … BdlYear 2011 Financial Transparency System

Text

Inserm Transfert SA, Paris, France

01/01/2011 EU funding: Hemibio - Health-2010-266777
01/01/2011 EU funding (€233,080): Tinn2
01/01/2011 EU funding (€329,000): Screentox
01/12/2011 EU funding (€337,861): Innovative Strategies to Generate Human Hepatocytes for Treatment of Metabolic Liver Diseases: Tools for Personalized Cell Therapy
01/01/2011 EU funding (€413,878): Hemibio
01/03/2011 EU funding (€420,000): Phase I/II ex Vivo Gene Therapy Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using Skin Equivalent Grafts Genetically Corrected with a COL7A1-Encoding SIN Retroviral Vector

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Inserm Transfert SA, Paris, France.

Creative Commons License The visualizations for "Inserm Transfert SA - 6 EU fundings (total €1,733,820): Innovative Strategies to Generate Human Hepatocytes for Treatment of Metabolic Liver Diseases: Tools for Personalized Cell Therapy …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close